Evidence check: Helicobacter in the context of blood sugar

The link between Helicobacter pylori infection and blood sugar levels is an area of active but inconclusive research. Some observational studies suggest a modest association between H. pylori seropositivity and higher fasting glucose or HbA1c, particularly in individuals with insulin resistance or type 2 diabetes. However, effect sizes are small, and confounding factors (e.g., socioeconomic status, overall inflammation) are difficult to rule out. Randomized trials of H. pylori eradication have not consistently shown improvements in glycemic control. The evidence is therefore moderate at best. Proposed mechanisms include effects on ghrelin, leptin, and systemic inflammation, but these remain hypothetical. For consumers: a positive H. pylori finding from a microbiome or DNA test (e.g., MyBody-X) does not explain or predict blood sugar issues. Clinical assessment with standard lab tests (HbA1c, fasting glucose, OGTT) is essential. The test results are not diagnostic for diabetes or prediabetes.